Academician
MEHMET ÖZCAN
ARAŞTIRMA GÖREVLİSİ (Unvan:Doçent)
ZONGULDAK BÜLENT ECEVİT ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Biyokimya
A quick look at recorded outputs — details below.
- Articles 40
- Projects 0
- Books 3
- Proceedings 21
- Patents 0
- Artistic 0
Scopus (SJR)
Q1
24
Q2
10
Q3
2
Q4
2
WoS (JCR)
Q1
22
Q2
11
Q3
2
Q4
1
TR Index
12
articles
Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.
Top 1% articles
2
Top 10% articles
4
Avg percentile
54.3%
Top 1% share
3.9%
Top 10% share
7.8%
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Article list
- 2026 Within- and Between-Subject biological variation estimates of serum free light immunoglobulin chains in healthy individuals in Turkey YÖKSİS SJR Q1 JCR Q1 OpenAlex 73.7%
- 2026 Biological variation estimates of direct and indirect LDL cholesterol by Friedewald and Martin-Hopkins formulas in healthy individuals YÖKSİS SJR Q3 JCR Q3 OpenAlex 57.1%
- 2026 Unexplored Natural Compounds as Dual Inhibitors of Cholinesterase and Ferroptosis: A Neuroprotective Perspective on Seven Bioactive Phytochemicals YÖKSİS TR Index OpenAlex 17.1%
- 2025 ASSESSING THE POTENTIAL OF HYPOXIA-TARGETING AGENTS AS GSTP1 INHIBITORS IN OVERCOMING CANCER DRUG RESISTANCE YÖKSİS TR Index OpenAlex 84.5%
- 2025 KLİNİK LABORATUVARDA KAN ÖRNEKLERİNDEKİ RET ORANLARININ DEĞERLENDİRİLMESİ YÖKSİS OpenAlex 1.5%
- 2025 Mucosal Wetness, Hyposalivation, and Local Defense in Periodontal Inflammation YÖKSİS SJR Q1 JCR Q1 OpenAlex 7.2%
- 2025 Synthesis and biological assessment of BUB1B inhibitors for the treatment of clear cell renal cell carcinoma YÖKSİS SJR Q1 JCR Q1 OpenAlex 88.9%
- 2025 The effect of the combination therapy with chlorophyllin, a glutathione transferase P1-1 inhibitor, and docetaxel on triple-negative breast cancer invasion and metastasis in vivo/in vitro YÖKSİS SJR Q2 JCR Q2 OpenAlex 80.6%
- 2025 Investigation of the inhibitory effects of the telomere-targeted compounds on glutathione S-transferase P1 YÖKSİS SJR Q2 JCR Q2 OpenAlex 66.3%
- 2025 Exploring the GSTP1 inhibition potential of photosensitizer compounds for enhanced cancer treatment in photodynamic therapy YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.3%
- 2025 Evaluation of GSTP1 Inhibition Potentials and Pharmacokinetic Properties of Stigmasterol, Sesamin, and Pinosylvin YÖKSİS TR Index OpenAlex 8.1%
- 2025 Molecular Docking Study for Phenazine Derivative Compounds: Cholinesterases and Alzheimer’s disease YÖKSİS OpenAlex 21.2%
- 2024 Investigation of the Effects of Biotinidase Deficiency on Plasma Cholinesterase Activity YÖKSİS TR Index SJR Q4 OpenAlex 15.5%
- 2024 Design and evaluation of novel inhibitors for the treatment of clear cell renal cell carcinoma YÖKSİS SJR Q1 JCR Q1 OpenAlex 77.7%
- 2024 Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach YÖKSİS SJR Q1 JCR Q1 OpenAlex 72.0%
- 2024 Effects of Photobiomodulation Application on Glutathione‐Related Antioxidant Defense System in Rabbit Eye Tissues YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.6%
- 2024 Novel drug targets and molecular mechanisms for sarcopenia based on systems biology YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.2%
- 2023 Comprehensive biomarker analysis of patients with idiopathic pulmonary fibrosis and interstitial lung disease with healthy individuals YÖKSİS SJR Q2 JCR Q2 OpenAlex 12.8%
- 2023 Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma YÖKSİS SJR Q1 JCR Q1 OpenAlex 83.4%
- 2023 Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy YÖKSİS SJR Q1 JCR Q1 OpenAlex 72.4%